Showing results (171-180 of 466) with videos related to
Sort By:
Pageof 47
Journal of the Royal Army Medical Corps|May 13, 2017
Deep and profound hypothermia in haemorrhagic shock, friend or foe? A systematic reviewSamuel E Moffatt, S J B Mitchell, J L WalkeOncology Research|January 1, 1996
Lisofylline as a modifier of radiation therapyJ S Wong, G Ara, S R Keyes, et al.Cancer Treatment Reports|May 1, 1987
Third-line chemotherapy for resistant Hodgkin's disease with lomustine, etoposide, and methotrexateA Tseng, C Jacobs, C N Coleman, et al.International Journal of Radiation Oncology, Biology, Physics|June 15, 1994
A phase I study of etanidazole and radiotherapy in malignant gliomaN E Riese, J S Loeffler, P Wen, et al.Annals of Internal Medicine|January 1, 1982
Functional hyposplenia after splenic irradiation for Hodgkin's diseaseC N Coleman, I R McDougall, M O Dailey, et al.International Journal of Radiation Oncology, Biology, Physics|April 1, 1989
Initial results of a phase I trial of continuous infusion SR 2508 (etanidazole): a radiation therapy oncology group studyC N Coleman, L Noll, A E Howes, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 1, 1992
A prospective study of hprt mutant and mutation frequencies in treated cancer patientsM Caggana, H L Liber, C N Coleman, et al.Gynecologic Oncology|May 1, 1984
The current status of drug development of hypoxic cell radiosensitizers and their potential role in gynecologic oncologyC N Coleman, S C Ballon, A E Howes, et al.Cancer Research|October 1, 1985
Depletion of cellular glutathione by exogenous spermine in V79 cells: implications for spermine-induced hyperthermic sensitizationA Russo, J B Mitchell, W DeGraff, et al.Biochemical Pharmacology|October 7, 1994
Free radical modes of cytotoxicity of adriamycin and streptonigrinW DeGraff, S M Hahn, J B Mitchell, et al.Pageof 47